FDA
approval
· 2021-06-04
FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
Summary
FDA approved a supplemental application for the generic fixed-dose combination tablet irbesartan and hydrochlorothiazide. The product is manufactured by Macleod…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)